The Centers for Medicare & Medicaid Services today released two additional resources to help facilities and providers implement provisions of the No Surprises Act that go into effect Jan. 1, 2022. Specifically, the agency released a series of Frequently Asked Questions related to the good faith estimates that must be provided to uninsured and self-pay patients for most scheduled services or upon request. In addition, the agency, along with the Department of Health and Human Services, released a “Patient-Provider Dispute Resolution Guidance Package.” These guidance documents are intended to help providers, facilities, and uninsured/self-pay patients better understand what information must be included in the good faith estimate and how to initiate the patient-provider dispute resolution process. The guidance package for facilities and providers may be accessed here. 
 
The AHA today also released additional materials to the field, including an updated set of FAQs related to the balance billing notice and consent process. Those FAQs may be accessed in the notice and consent section of the AHA’s surprise billing Implementation Guide. Many of the provisions of the No Surprises Act go into effect Jan. 1, 2022. AHA continues to encourage all facilities and providers to ensure they are aware of these new requirements. More information, including links to additional resources, may be found on the AHA’s surprise billing webpage.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The AHA on Aug. 14 at 1 p.m. ET will host a webinar on age-friendly health systems and how they can strengthen care delivery. Adam Koontz, senior director of…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Perspective
House members are back in their districts for the August recess and senators are likely to return to their states soon.While lawmakers are home, it’s important…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…